Screening for the Prevalence of EGFR and Alk Mutations in Lung Adenocarcinoma Patients in the Levant Area, a Prospective Analysis

A. Tfayli; M. Khalil; A. Mina; H. Rafei; N. Fakhreddin; R. Mahfouz; F. Farhat; S. Hamouri; H. Dbouk; G. Zaatari

Journal ArticleOPEN ACCESS

Screening for the Prevalence of EGFR and Alk Mutations in Lung Adenocarcinoma Patients in the Levant Area, a Prospective Analysis

Tfayli A
Khalil M
Mina A
et al.

Annals of Oncology (2015) 26 i1

DOI: 10.1093/annonc/mdv043.05

N/ACitations

1Readers

Cite

CITATION STYLE

APA

Tfayli, A., Khalil, M., Mina, A., Rafei, H., Fakhreddin, N., Mahfouz, R., … Zaatari, G. (2015). Screening for the Prevalence of EGFR and Alk Mutations in Lung Adenocarcinoma Patients in the Levant Area, a Prospective Analysis. Annals of Oncology, 26, i1. https://doi.org/10.1093/annonc/mdv043.05

Screening for the Prevalence of EGFR and Alk Mutations in Lung Adenocarcinoma Patients in the Levant Area, a Prospective Analysis

Cite

Register to see more suggestions